Palm Desert Testing Site - Get Tested For COVID-19 Today

Palm Desert Location

72-840 CA-111 Palm Desert, CA 92260 
Located across the parking lot from Barnes and Noble.

This is a drive-through testing location and is located in the parking lot. Patients can stay in the safety of their vehicle.

The State of California only counts PCR tests. If you would like your result to be counted by California and contribute toward Riverside County's testing numbers please select the Standard Molecular NAAT Test or the Rapid RT-PCR Test.

Patients may be able to receive reimbursement from their health insurance company for all or a portion of their COVID-19 test. Please contact your insurance company for additional information as to whether you may be eligible to receive reimbursement for your COVID-19 test and how to apply. Click Here to see an example of the invoice each patient receives for their test(s).

Tests Available At This Location

Click on a test heading to see additional information

  • $99 Rapid COVID-19 IgG/IgM Antibody
  • $125 Standard Molecular NAAT (PCR or TMA) COVID-19 Test
  • $150 Rapid COVID-19 Antigen Test
  • $175 Rapid COVID-19 Antigen + Flu Combo Test
  • $299 Rapid COVID-19 Molecular NAAT Test
  • $475 Rapid RT-PCR COVID-19 Test (Best for Travel)

Rapid COVID-19 IgG/IgM Antibody Test

Results are generally reported within 60 minutes at most locations.

Assure COVID-19 IgG/IgM Rapid Test Device

  • IgG: This is the most common antibody. It’s in blood and other body fluids, and protects against bacterial and viral infections. IgG can take time to form after an infection or immunization.
  • IgM: Found mainly in blood and lymph fluid, this is the first antibody the body makes when it fights a new infection.

The Assure COVID-19 IgG/IgM Rapid Test Device, a test for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 (often referred to as COVID-19 or the novel coronavirus) in human venous whole blood (sodium EDTA), serum, plasma (sodium EDTA) and fingerstick whole blood.

The Assure COVID-19 IgG/IgM Rapid Test Device is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity

September 23, 2020 and the FDA guidance, “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency” issued on March 16, 2020 (updated May 11, 2020). The

  • FDA issued this guidance to help accelerate the availability of novel coronavirus (COVID-19) tests developed by laboratories and commercial manufacturers during the public health emergency. This test has not been FDA cleared or approved; this test has been authorized by FDA under an EUA for use by laboratories certified under CLIA, that meet requirements to perform waived, moderate or high complexity test;
  • This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens;
  • This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1),
    unless the authorization is terminated or revoked sooner.
  • Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. The sensitivity of the EcoTest COVID-19 IgG/IgM Rapid Test Device early after infection is unknown. If acute infection is suspected, direct testing for SARS-CoV-2 is necessary.
  • Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status;
  • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.

Standard Molecular NAAT (PCR or TMA) COVID-19 Test

Results are generally reported within two to four days

Covid Clinic utilizes multiple independent laboratories to process specimens collected and multiple molecular tests in order to offer PCR or TMA testing on a consistent basis. The molecular NAAT PCR or TMA test will be one of the following three tests, but Covid Clinic is unable to guarantee which of the tests will be utilized for a specific sample:

Roche cobas SARS-CoV-2 RT-PCR

Hologic Aptima SARS-CoV-2 Assay

LabCorp COVID-19 RT PCR Test

Test Information

Covid Clinic is happy to offer COVID-19 PCR or TMA testing services. This testing meets the requirements for most travel restrictions; however, it is the purchaser’s responsibility to review any applicable travel restrictions prior to booking an appointment in order to ensure the service will meet the patient’s travel restriction requirement(s).

The specimen is collected by a nasal (anterior nares) swab. Please note that most travel restrictions require that a traveler’s test specimen IS COLLECTED within 48 to 72 hours upon arrival at destination. Results for the Standard Molecular NAAT (PCR or TMA) COVID-19 Test are generally reported to the patient within two to four days, but this delivery time is not guaranteed. If a patient needs their result delivered with a guaranteed turnaround time please see Covid Clinic’s Expedited Molecular NAAT (PCR or TMA) COVID-19 Test service offering.

Testing specimens collected at Covid Clinic are sent to third-party laboratories for processing. These laboratories may bill the patient’s insurance for their services. Covid Clinic strongly encourages all patients to provide any insurance information so patients may be able to avoid being billed directly by the third-party laboratory that processes the patient’s specimen. If a patient is uninsured, the third-party lab processing the specimen may attempt to collect public funding in lieu of billing the patient.

Rapid COVID-19 Antigen Test

Results are generally reported within 60 minutes at most locations.

Covid Clinic utilizes multiple antigen tests in order to make antigen testing more accessible. The antigen test administered to the patient will be one of the following three tests, but Covid Clinic is unable to guarantee which of the tests will be utilized for a specific patient.

Quidel Corporation Sofia SARS Antigen FIA Test

Access Bio, Inc. CareStart COVID-19 Antigen Test

Luminostics, Inc. Clip COVID Rapid Antigen Test

Test Information

All of Covid Clinic’s antigen test offerings utilize tests that have received emergency use authorization from the FDA.

For Quidel’s Sofia SARS Antigen FIA Test and Luminostics Clip COVID Rapid Antigen Test, the specimen is collected by a nasal swab. The cotton swab does not need to be inserted far into the nose, and is rotated in a circle around the entire inside edge of each nostril at least three times. Results are generally available within 60 minutes and delivered to the patient via email (with the individual’s consent).

For Access Bio’s CareStart COVID-19 Antigen Test, the specimen is collected by a nasopharyngeal swab. Results are generally available within 60 minutes and delivered to the patient via email (with the individual’s consent).

COVID-19 Antigen + Flu Combo Test

Three tests in one! This test is recommended for all individuals and especially those with symptoms

Tests for COVID-19, Influenza A, and Influenza B

Results are generally reported within 60 minutes

Test Information

Covid Clinic is offering the Quidel Corporation Sofia 2 FLU + SARS Antigen FIA Test. This test has received an emergency use authorization from the FDA.

The specimen is collected by a nasal swab. The cotton swab does not need to be inserted far into the nose, and is rotated in a circle around the entire inside edge of each nostril at least three times. Results are generally available within 60 minutes although result time may vary from location to location.

Rapid COVID-19 Molecular NAAT Test

Abbott ID Now COVID-19 Assay

Results are generally reported within 60 minutes at most locations.

Test Information

Covid Clinic, Inc. is offering the Abbott ID Now COVID-19 Assay performed on the ID NOW Instrument. This test is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology intended for the qualitative detection of nucleic acid from the SARS-CoV-2 viral RNA in direct nasal swabs. The ID Now COVID-19 Assay has received Emergency Use Authorization (EUA) from the FDA.

Many travel restrictions require a molecular or NAAT test be conducted prior to arrival. Abbott’s ID Now COVID-19 test may satisfy these requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase.

The tip of the cotton swab is inserted into both nostrils. The swab does not need to be inserted far, just until the cotton tip of the swab is no longer visible. The swab is then rotated in a circle around the entire inside edge of each nostril at least three times.

Rapid RT-PCR COVID-19 Test

Results are generally reported within two hours

Satisfies most travel restriction requirements

Collected by anterior nares nasal swab (front of the nose only)

Test Information

The Rapid RT-PCR COVID-19 Test is a molecular, in vitro diagnostic test utilizing end point reverse transcriptase polymerase chain reaction (RT-PCR) and lateral flow technologies for the qualitative, visual detection of the coronavirus SARS-CoV-2 viral RNA. The four steps utilized to perform the test are lysis of the virus, reverse transcription of viral RNA to cDNA, nucleic acid amplification, and detection.

The Rapid RT-PCR COVID-19 Test has been released under FDA Emergency Use Authorization (EUA) for the detection of nucleic acid from SARS-CoV-2 (the virus responsible for COVID-19 infection), and can be used in applications that require molecular/ RT-PCR testing. Please consult your state health department for additional information regarding specific uses (such as pre and post travel requirements). Many travel restrictions require a RT-PRC, molecular, or NAAT test be conducted prior to arrival at the destination. The Rapid RT-PCR COVID-19 test satisfies most travel requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase.

Rapid COVID-19 IgG/IgM Antibody Test

Results are generally reported within 60 minutes at most locations.

Assure COVID-19 IgG/IgM Rapid Test Device

  • IgG: This is the most common antibody. It’s in blood and other body fluids, and protects against bacterial and viral infections. IgG can take time to form after an infection or immunization.
  • IgM: Found mainly in blood and lymph fluid, this is the first antibody the body makes when it fights a new infection.

The Assure COVID-19 IgG/IgM Rapid Test Device, a test for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 (often referred to as COVID-19 or the novel coronavirus) in human venous whole blood (sodium EDTA), serum, plasma (sodium EDTA) and fingerstick whole blood.

The Assure COVID-19 IgG/IgM Rapid Test Device is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity

September 23, 2020 and the FDA guidance, “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency” issued on March 16, 2020 (updated May 11, 2020). The

  • FDA issued this guidance to help accelerate the availability of novel coronavirus (COVID-19) tests developed by laboratories and commercial manufacturers during the public health emergency. This test has not been FDA cleared or approved; this test has been authorized by FDA under an EUA for use by laboratories certified under CLIA, that meet requirements to perform waived, moderate or high complexity test;
  • This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens;
  • This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1),
    unless the authorization is terminated or revoked sooner.
  • Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. The sensitivity of the EcoTest COVID-19 IgG/IgM Rapid Test Device early after infection is unknown. If acute infection is suspected, direct testing for SARS-CoV-2 is necessary.
  • Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status;
  • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.

Standard Molecular NAAT (PCR or TMA) COVID-19 Test

Results are generally reported within two to four days

Covid Clinic utilizes multiple independent laboratories to process specimens collected and multiple molecular tests in order to offer PCR or TMA testing on a consistent basis. The molecular NAAT PCR or TMA test will be one of the following three tests, but Covid Clinic is unable to guarantee which of the tests will be utilized for a specific sample:

Roche cobas SARS-CoV-2 RT-PCR

Hologic Aptima SARS-CoV-2 Assay

LabCorp COVID-19 RT PCR Test

Test Information

Covid Clinic is happy to offer COVID-19 PCR or TMA testing services. This testing meets the requirements for most travel restrictions; however, it is the purchaser’s responsibility to review any applicable travel restrictions prior to booking an appointment in order to ensure the service will meet the patient’s travel restriction requirement(s).

The specimen is collected by a nasal (anterior nares) swab. Please note that most travel restrictions require that a traveler’s test specimen IS COLLECTED within 48 to 72 hours upon arrival at destination. Results for the Standard Molecular NAAT (PCR or TMA) COVID-19 Test are generally reported to the patient within two to four days, but this delivery time is not guaranteed. If a patient needs their result delivered with a guaranteed turnaround time please see Covid Clinic’s Expedited Molecular NAAT (PCR or TMA) COVID-19 Test service offering.

Testing specimens collected at Covid Clinic are sent to third-party laboratories for processing. These laboratories may bill the patient’s insurance for their services. Covid Clinic strongly encourages all patients to provide any insurance information so patients may be able to avoid being billed directly by the third-party laboratory that processes the patient’s specimen. If a patient is uninsured, the third-party lab processing the specimen may attempt to collect public funding in lieu of billing the patient.

Rapid COVID-19 Antigen Test

Results are generally reported within 60 minutes at most locations.

Covid Clinic utilizes multiple antigen tests in order to make antigen testing more accessible. The antigen test administered to the patient will be one of the following three tests, but Covid Clinic is unable to guarantee which of the tests will be utilized for a specific patient.

Quidel Corporation Sofia SARS Antigen FIA Test

Access Bio, Inc. CareStart COVID-19 Antigen Test

Luminostics, Inc. Clip COVID Rapid Antigen Test

Test Information

All of Covid Clinic’s antigen test offerings utilize tests that have received emergency use authorization from the FDA.

For Quidel’s Sofia SARS Antigen FIA Test and Luminostics Clip COVID Rapid Antigen Test, the specimen is collected by a nasal swab. The cotton swab does not need to be inserted far into the nose, and is rotated in a circle around the entire inside edge of each nostril at least three times. Results are generally available within 60 minutes and delivered to the patient via email (with the individual’s consent).

For Access Bio’s CareStart COVID-19 Antigen Test, the specimen is collected by a nasopharyngeal swab. Results are generally available within 60 minutes and delivered to the patient via email (with the individual’s consent).

COVID-19 Antigen + Flu Combo Test

Three tests in one! This test is recommended for all individuals and especially those with symptoms

Tests for COVID-19, Influenza A, and Influenza B

Results are generally reported within 60 minutes

Test Information

Covid Clinic is offering the Quidel Corporation Sofia 2 FLU + SARS Antigen FIA Test. This test has received an emergency use authorization from the FDA.

The specimen is collected by a nasal swab. The cotton swab does not need to be inserted far into the nose, and is rotated in a circle around the entire inside edge of each nostril at least three times. Results are generally available within 60 minutes although result time may vary from location to location.

Rapid COVID-19 Molecular NAAT Test

Abbott ID Now COVID-19 Assay

Results are generally reported within 60 minutes at most locations.

Test Information

Covid Clinic, Inc. is offering the Abbott ID Now COVID-19 Assay performed on the ID NOW Instrument. This test is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology intended for the qualitative detection of nucleic acid from the SARS-CoV-2 viral RNA in direct nasal swabs. The ID Now COVID-19 Assay has received Emergency Use Authorization (EUA) from the FDA.

Many travel restrictions require a molecular or NAAT test be conducted prior to arrival. Abbott’s ID Now COVID-19 test may satisfy these requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase.

The tip of the cotton swab is inserted into both nostrils. The swab does not need to be inserted far, just until the cotton tip of the swab is no longer visible. The swab is then rotated in a circle around the entire inside edge of each nostril at least three times.

Rapid RT-PCR COVID-19 Test

Results are generally reported within two hours

Satisfies most travel restriction requirements

Collected by anterior nares nasal swab (front of the nose only)

Test Information

The Rapid RT-PCR COVID-19 Test is a molecular, in vitro diagnostic test utilizing end point reverse transcriptase polymerase chain reaction (RT-PCR) and lateral flow technologies for the qualitative, visual detection of the coronavirus SARS-CoV-2 viral RNA. The four steps utilized to perform the test are lysis of the virus, reverse transcription of viral RNA to cDNA, nucleic acid amplification, and detection.

The Rapid RT-PCR COVID-19 Test has been released under FDA Emergency Use Authorization (EUA) for the detection of nucleic acid from SARS-CoV-2 (the virus responsible for COVID-19 infection), and can be used in applications that require molecular/ RT-PCR testing. Please consult your state health department for additional information regarding specific uses (such as pre and post travel requirements). Many travel restrictions require a RT-PRC, molecular, or NAAT test be conducted prior to arrival at the destination. The Rapid RT-PCR COVID-19 test satisfies most travel requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase.

Book an Appointment